Drugs
Xeloda
Generic Name: Capecitabine
Product Name: Xeloda
- Indication of Xeloda
- Action of Xeloda
- Dose advice of Xeloda
- Schedule of Xeloda
- Common side effects of Xeloda
- Uncommon side effects of Xeloda
- Reference
Indication of Xeloda:
Xeloda is used in the treatment of advanced or metastatic colorectal cancer. It can also be used to treat advanced or metastatic breast cancer when treatment with taxanes and anthracyclines has failed, or if these agents are contraindicated. After failure of anthracycline containing therapy, Xeloda should be used in combination with docetaxal.Action of Xeloda:
Capecitabine is an oral antineoplastic agent that is metabolised to its active form, 5-fluorouracil, an enzyme that is found in tumours. 5-fluorouracil is an antineoplastic drug known as an antimetabolite. After entering cells and being activated, it interferes with the replication of rapidly dividing cells (including cancer cells) by preventing the conversion of folic acid to folinic acid, a building block for new DNA. 5-fluorouracil aims to reduce tumour size and prolong life for cancer sufferers.Dose advice of Xeloda:
Tablets should be swallowed with water 30 minutes after meals.If it is the only drug being taken:Schedule of Xeloda:
S4Common side effects of Xeloda:
The following effects are seen very commonly:Uncommon side effects of Xeloda:
The following effects have been observed less commonly:Reference:
[1] Consumer Medical Information[2] MIMS Australia. MIMSOnline Prescribing Information: Xeloda [online]. 2003 [cited: 23/6/03]. Available from URL: http://proxy8.use.hcn.com.au/ifmx-nsapi/mims-data/?MIval=2MIMS_abbr_pi&product_code=4745&product_name=Xeloda#.[3] Professional InformationDiseases treated by Xeloda:
- Bowel Cancer (Adenocarcinoma of the Caecum)
- Breast Cancer (Carcinoma of the Breast)
- Breast Cancer (Inflammatory Carcinoma of the Breast)
- Breast Cancer (Pre-Invasive Ductal Carcinoma; Ductal Carcinoma In Situ; DCIS)
- Breast Cancer (Pre-Invasive Lobular Carcinoma; Lobular Carcinoma In Situ; LCIS)
- Colon Cancer (Adenocarcinoma of the Colon)
- Rectal Cancer (Adenocarcinoma of the Rectum)
Regimens that include Xeloda:
- Capecitabine
- Capecitabine + Docetaxel
- Capecitabine + Oxaliplatin
- Capecitabine + Paclitaxel
- MAX (Mitomycin C + Capecitabine + Bevacizumab)
- XELIRI (capecitabine + irinotecan)
- XELOX (Capecitabine + Oxaliplatin)
For further information talk to your doctor.
Article Dates:
|
|







